Michael Lichtenauer

Michael Lichtenauer is a researcher at the Paracelsus Medical University in the Department of Internal Medicine II - Division of Cardiology. With over 526 research outputs, his work focuses on cardiopulmonary complications, biomarkers, and metabolic changes in cardiovascular diseases.

• Active in Congestive Heart Failure and Aortic Valve Stenosis research
• Recipient of multiple awards including the Clinical Case Award 1. Platz ESC Heart Failure Kongress 2018
• Collaborated on studies involving COVID-19, Myocarditis, and Transcatheter Aortic Valve Replacement

His research explores biomarkers for prognostic tools in heart surgery and metabolic impacts in spaceflight analogs. Recent work includes long-term effects of severe COVID-19 infection on cardiopulmonary systems.

• Abstract Preis - 3. Platz (Kardiologie im Zentrum Linz), 2016
• Österreichischer Kardiologenpreis der ÖKG 1. Platz Basic Science, 2011
• Researcher of the Month, MedUni Wien, 2012

Lichtenauer contributes to peer-review processes and organizes academic events like ESC Update and Forschungsmeeting Sudelfeld. His work bridges clinical cardiology and molecular biomarker analysis.